The region's overall declining health, backed by the outbreak of swine flu, has given vendors of ventilation systems and associated airway management devices many reasons to cheer.
New analysis from Frost & Sullivan (patientmonitoring.frost.com), European Market for Ventilation and Airway Management Devices, finds that the market with both multimodal and niche market participants is in a growth phase, earned revenues of $559.7 million in 2009 and is estimated to reach $851.6 million in 2014.
Dominant European markets, such as France, the United Kingdom and Germany, are highly competitive, fuelled by the desire among market players to cater to the greater population and capitalize on saturating opportunities.
But market stability and growth is threatened. Challenges, such as the intensity of competition, price wars, homogenous products and the demand for multi-modal ventilators, continue to beset the European market. Even certain hospitals are investing in alternative patient monitoring equipment, thereby lowering the sale potential of ventilators. Such hospitals tend to use this equipment for extended periods, elongating the replacement cycle and curbing the growth of the market.
In this market, where the presence of multinational companies has burgeoned competition, product differentiation will help individual companies carve their own niche. Vendors will be pleased with the improving end-user awareness about ventilation devices and the techniques involved. This not only enhances adaptability among patients, but also increases the level of technology acceptance in hospitals.
"Increased spending on product development, promoting the differentiation and optimization of distribution in answer to end-user needs, is critical for success in this market," says Somsainathan. "The challenge is to maintain a healthy cost-benefit ratio while including high-end technology to improve the effectiveness and accuracy of ventilator devices."
Demand for home care ventilation devices has thus far outstripped the demand for hospital care, primarily due to increasing cases of sleep apnea. In order to make their solutions more precise and efficient, market participants should look at expanding their revenue streams by incorporating comprehensive and user-friendly technology. They should take note of the market's maturity levels and optimise their distribution channels, while innovating solutions for deeper penetration, as most of the top-line market will already have been tapped.
"Designing efficient sales strategies will augment the market's penetration rates and brand visibility," notes Somsainathan. "Further, superior after-sales service and training will help achieve greater customer satisfaction and brand reputation."
If you are interested in more information on Frost & Sullivan's latest study on the European Market for Ventilation and Airway Management Devices, please send an email to Katja Feick, Corporate Communications, at katja.feick[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.
European Market for Ventilation and Airway Management Devices is part of the Patient Monitoring Growth Partnership Services programme, which also includes research in the following markets: European Remote Patient Monitoring Market, European Market for non- Invasive Blood Pressure Monitors, European Telemetry Equipment Market and European Pulse Oximetry Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
European Market for Ventilation and Airway Management Devices / M55F